Summary
(±)[125Iodo]cyanopindolol (ICYP) is a radioligand which binds with an extraordinarily high affinity and specificity to β-adrenoceptors. In contrast to (±)[125Iodo]-hydroxybenzylpindolol (IHYP), the new ligand has neither affinity to α- nor to 5-HT-receptors. The dissociation constants of ICYP for β-adrenoceptors in various tissues range from 27 to 40 pM, thereby exceeding the affinity of IHYP by a factor of ∼ 3.
ICYP does not discriminate between β1− and β2−. Therefore, the densities of the two receptor subtypes can be determined from competition curves of ICYP by drugs previously found to show in vitro selectivity for β1−adrenoceptors.
The guinea pig left ventricle contains only β1− adrenoceptors, whereas in the lung tissue, the ratio of β1− to β2−adrenoceptors is 1 to 4. The calculated affinities of five β1− selective antagonists for β1−adrenoceptors were nearly identical in the ventricle and the lung.
Kinetic studies of ICYP binding to guinea pig lung membranes indicated that the dissociation reaction consists of two components, a fast process (t 1/2=9 min) and a slower process (t 1/2=8.8 h). A mathematical treatment revealed two possibilities of interpretation: 1. Two forms of the receptor exist which are interconvertible. 2. The (+)- and (−)-enantiomers of ICYP dissociate with different rate constants.
The low dissociation constant of ICYP in combination with its high specific radioactivity (2175 Ci mmole−1) allows binding studies to be carried out with small protein and ligand concentrations, e.g. 3 μg protein per assay in guinea pig lung membranes.
Similar content being viewed by others
Abbreviations
- CYP:
-
(±)cyanopindolol, [(±)4-(3-tert-butylamino-2-hydroxypropoxy)-1H-indole-2-carbonitrile]
- ICYP:
-
(±)-3-[125iodo]-cyanopindolol
- HYP:
-
(±)hydroxybenzylpindolol; IHYP, (±)[125iodo]-hydroxybenzylpindolol
- 3H-DHA:
-
(−)-[3H]dihydroalprenolol
References
Ablad B, Borg KD, Carlsson E, Ek L, Johnsson G, Malmfors T, Regardh CG (1975) A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 36, Suppl V: 7–24
Aggerbeck M, Guellaen G, Hanoune J (1979) N-aralkyl substitution increases the affinity of adrenergic drugs for the α-adrenoceptor in rat liver. Br J Pharmacol 65:155–159
Atlas D, Steer ML, Levitzki A (1974) Stereospecific binding of propranolol and catecholamines to beta-adrenergic receptor. Proc Natl Acad Sci USA 71:4246–4248
Aurbach GD, Fedak SA, Woodard CJ, Palmer JS, Hauser D, Troxler F (1974) β-adrenergic receptor: stereospecific interaction of iodinated β-blocking agent with high affinity site. Science 186:1223–1224
Barnes PJ, Dollery CT, MacDermot J (1980) Increased pulmonary α-adrenergic and reduced β-adrenergic receptors in experimental asthma. Nature 285:569–571
Barovsky K, Brooker G (1980) (−)-[125I]-iodopindolol, a new highly selective radioiodinated β-adrenergic receptor antagonist: measurement of β-adrenoceptors in intact rat astrocytoma cells. J Cycl Nucleotide Res 6:297–307
Barrett AM (1977) The pharmacology of atenolol. Postgrad Med J 53, Suppl 3: 58–64
Bearer CF, Knapp RD, Kaumann AJ, Swartz TL, Birnbaumer L (1980) Iodohydroxybenzylpindolol: preparation, purification, localization of its iodine to the indole ring and characterization as a partial agonist. Mol Pharmacol 17:328–338
Berman M (1968) The application of multicomportmental analysis to problems of clinical medicine. Ann Intern Med 68:423–448
Berman M, Weiss MF (1967) SAAM Manual. NIH PHS Publication, 1703, Bethesda/Maryland, USA
Berthold R (1979) Br Pat Publ 2001971A and D.O.S. 2830211
Bieth N, Rouot B, Schwartz J, Velly J (1980) Comparison of pharmacological and binding assays for ten β-adrenoceptor blocking agents and two β-adrenoceptor agonists. Br J Pharmacol 68:563–569
Boudot JP, Cavero I, Fenard S, Lefevre-Borg F, Manoury P, Roach AG (1979) Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist. Br J Pharmacol 66:445P
Bürgisser E, Hancock AA, Lefkowitz RJ, De Lean A (1981) Anomalous equilibrium binding properties of high affinity racemic radioligands. Mol Pharmacol 19:205–216
Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant K1 and the concentration of inhibitor which caused 50% inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Dickinson KEJ, Nahorski SR, Willcocks AL (1981) Serotonin recognition sites are labelled in cerebral cortex by the β-adrenoceptor antagonist 125I-hydroxybenzylpindolol. Br J Pharmacol 72:165P
Dunlop D, Shanks RG (1968) Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol 32:201–218
Hancock AA, De Lean AL, Lefkowitz RJ (1980) Quantitative resolution of beta-adrenergic subtypes by selective ligand binding: application of a computerized model fitting technique. Mol Pharmacol 16:1–9
Harden TK, Wolfe BB, Molinoff PB (1976) Binding of iodinated β-adrenergic antagonists to proteins derived from rat heart. Mol Pharmacol 12:1–15
Hedberg A, Minneman KP, Molinoff PB (1980) Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea pig heart. J Pharmacol Exp Ther 212:503–508
Hoffmann BB, Lefkowitz RJ (1980) Radioligand binding studies of adrenergic receptors: new insights into molecular and physiological regulation. Annu Rev Pharmacol Toxicol 20:581–608
Hoyer D, Engel G, Berthold R. Binding characteristics of (+)-, (±)- and (−)-[125iodo]cyanopindolol to guinea pig left ventricle membranes. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
Hunter WM, Greenwood H (1962) Preparation of 131iodine labelled human growth hormone of high specific activity. Nature 194:495–496
Innis RB, Correa FMA, Snyder S (1979) Carazolol, an extremely potent β-adrenergic blocker: binding to β-adrenoceptors in brain membranes. Life Sci 24:2255–2264
Kaumann AJ, Birnbaumer L, Wittmann R (1978) Heart β-adrenoceptors. In: O'Malley BW, Birnbaumer L (eds) Hormone receptors 3. Academic Press, New York, pp 133–177
Kleinstein J, Glossmann H (1978) Solubilization of a mammalian β-adrenergic receptor. Naunyn-Schmiedeberg's Arch Pharmacol 305:191–200
Krawietz W, Weinsteiger M, Pruchniewski M, Erdmann E (1979) Evidence for negative cooperativity among β-adrenergic receptors in cardiac and lung tissue of guinea pig. Biochem Pharmacol 28:2999–3007
Laurell S, Tibbling G (1966) An enzymatic fluorometric micromethod for the determination of glycerol. Clinica Chimica Acta 13:317–322
Lefkowitz RJ, Mukherjee C, Coverstone M, Caron MG (1974) Stereospecific 3H-(−)-alprenolol binding sites, β-adrenergic receptors and adenylate cyclase. Biochem Biophys Res Commun 60:703–709
Lefkowitz RJ, Williams LT (1977) Catecholamine binding to the beta-adrenergic receptor. Proc Natl Acad Sci USA 74:515–519
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Maguire ME, Ross EM, Gilman AG (1977) β-adrenergic receptor: ligand binding properties and the interaction with adenylyl cyclase. In: Greengard P, Robison GA (eds) Advances in cyclic nucleotide research 8. Raven Press, New York, pp 1–84
Maguire ME, Wiklund RA, Anderson HJ, Gilman AG (1976) Binding of [125I]iodohydroxybenzylpindolol to putative β-adrenoceptors of rat glioma cells and other cell clones. J Biol Chem 251:1221–1231
Malchoff CD, Marinetti GV (1976) Hormone action at the membrane level. Binding of (±)-[3H]isoproterenol to intact chicken erythrocytes and erythrocyte ghosts. Biochem Biophys Acta 436:45–52
McNamara DB, Sulakhe PV, Singh JN, Dhalla NS (1974) Properties of heart sarcolemmal Na+-K+-ATPase. J Biochem 75:795–803
Minneman KP, Hegstrand LR, Molinoff PB (1979) Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol 16:34–46
Minneman KP, Molinoff PB (1980) Classification and quantitation of β-adrenergic receptor subtypes. Biochem Pharmacol 29:1317–1323
Morris TH, Kaumann AJ (1979) Characteristics of 3H-(±)-carazolol binding to myocardial β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 308:R33
Pochet R, Schmitt H (1978) In vivo labeling of β-adrenergic receptors from muscle cells. In: Dumont J, Nunez J (eds) Hormone and cell regulation 2. Elsevier/North-Holland Biomedical Press, pp 133–135
Rodbell M (1964) Metabolism of isolated fat cells. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375–380
Ross EM, Maguire ME, Sturgill TW, Biltonen RL, Gilman AG (1977) Relationship between the β-adrenergic receptor and adenylate cyclase. J Biol Chem 252:5761–5775
Rugg EL, Barnett DB, Nahorski SR (1978) Coexistence of β1− and β1− adrenoceptors in mammalian lung: evidence from direct binding studies. Mol Pharmacol 14:996–1005
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann NY Acad Sci USA 51:660–672
Snedecor GW, Cochran WG (1973) Curvilinear regression. In: Snedecor GW, Cochran WG (eds) Statistical methods, Chapter 15. The Iowa State Univ Press, Iowa/USA, 6th edition, pp 447–471
Sporn JR, Molinoff PB (1976) β-adrenoceptors in rat brain. J Cycl Nucleotide Res 2:149–161
Svendsen TL, Hartling O, Trap Jensen J (1979) Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89-406 in healthy volunteers. Eur J Clin Pharmacol 15:223–228
Schmitt H, Pochet R (1977) In vivo labelling of β-adrenergic receptors on rat glioma cells. FEBS Lett 76:302–305
Terasaki WI, Brooker G (1978) 125I-Iodohydroxybenzylpindolol binding sites on intact rat glioma cells. J Biol Chem 253:5418–5425
Waechter W, Muench U, Lemoine H, Kaumann AJ (1980) Evidence that (+)Bupranolol interacts directly with myocardial β-adrenoceptors. Control of optical purity with differential thermal analysis. Naunyn-Schmiedeberg's Arch Pharmacol 313:1–8
Wenke M (1971) Drug receptor interactions. In: Bacq ZM (ed) Fundamentals of Biochemical Pharmacology. Pergamon Press, Oxford, pp 367–415
Yamamura H, Rodbell M, Fain JN (1976) Hydroxybenzylpindolol and hydrobenzylpropranolol: Partial beta-adrenergic agonists of adenylate cyclase in the rat adipocyte. Mol Pharmacol 12:693–700
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Engel, G., Hoyer, D., Berthold, R. et al. (±)[125Iodo]cyanopindolol, a new ligand for β-adrenoceptors: Identification and quantitation of subclasses of β-adrenoceptors in guinea pig. Naunyn-Schmiedeberg's Arch. Pharmacol. 317, 277–285 (1981). https://doi.org/10.1007/BF00501307
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501307